primary cns lymphoma: focus on role of radiation
DESCRIPTION
Primary CNS Lymphoma: focus on role of radiation. Dr. Rico Liu Consultant, Department of Clinical Oncology, Queen Mary Hospital Honorary Clinical Associate Professor, Department of Clinical Oncology, The University of Hong Kong Deputy Hospital Chief Executive, Queen Mary Hospital. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/1.jpg)
Dr. Rico LiuConsultant, Department of Clinical Oncology, Queen Mary Hospital
Honorary Clinical Associate Professor, Department of Clinical Oncology, The University of Hong Kong
Deputy Hospital Chief Executive, Queen Mary Hospital
BTG 2013 Feb 2013
![Page 2: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/2.jpg)
Points for discussionEffects of radiation Radiotherapy is not for everyone but for
whom and when The role of new technology
![Page 3: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/3.jpg)
Effects of radiation
External Radiotherapy•High energy Xray
• Photon- •Gama ray- from radioactive decay, e.g. Colbert
•High energy particles• Electron• Proton
BrachytherapySystemic radiotherapy
apoptosis
![Page 4: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/4.jpg)
Effects of therapeutic radiation
![Page 5: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/5.jpg)
Normal tissue tolerance
Milano et al., Semin Radiat Oncol. 17 (2007): 131-140
![Page 6: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/6.jpg)
Treatment improves survival Median survival (mo)
Untreated ~2
WBRT alone ~12
Chemotherapy follows by WBRT
~ 48
Henry JM et al. Cancer 34: 1293, 1974 Nelson DF et al. IJROBP Volume 23, Issue 1, 1992, Pages 9–17Ferreri AJ et al. Ann Oncol. 2000 Aug;11(8):927-37
![Page 7: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/7.jpg)
PCNSL: Radiotherapy alone RTOG 8315
Phase II study of WBRT 40Gy + 20Gy boostN = 41Overall median survival 12.2 monthsBenefit of boost doubtful: disease recurrence
frequently occurred in the boosted field, survival nobetter than previous study without use of boost
Ocular involvement: 36Gy to both eyes (or Rxwith high dose MTX)
Nelson DF et al. IJROBP Volume 23, Issue 1, 1992, Pages 9–17
![Page 8: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/8.jpg)
PCNSL: Chemo + radiotherapy
CR 58%, PR 36% (Overall RR 94%) Overall survival 37 months 15% ( 12 patients) developed severe delayed neurologic toxicity
8 out of 12 died ( 5/8 from the group > 60 years of age and 3/8 from < 60 years of age)
![Page 9: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/9.jpg)
![Page 10: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/10.jpg)
Delayed neurotoxicity is worse for elderly patients
Omuro AM et al. Arch Neurol. 2005 Oct;62(10):1595-600
![Page 11: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/11.jpg)
![Page 12: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/12.jpg)
G-PCNSL-SG-1 trial
![Page 13: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/13.jpg)
Not enough evidence to forgo WBRTLimitations of the trial
Low statistical power High protocol violationsHigh rate of lost to follow upSmall sample size in the analysis of
neurotoxicity
![Page 14: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/14.jpg)
Lower dose of RT for patients with CR
![Page 15: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/15.jpg)
WBRT- set up
![Page 16: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/16.jpg)
Therapeutic management of PCNSL
Ferreri A J M Blood 2011;118:510-522Role of radiotherapy
![Page 17: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/17.jpg)
![Page 18: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/18.jpg)
![Page 19: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/19.jpg)
![Page 20: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/20.jpg)
The role of new technology
Neuro Oncol (August 2009) 11 (4): 423-429
![Page 21: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/21.jpg)
SummaryPCNSL is rareChemotherapy +/- radiotherapy offer the best
survival Delayed neurotoxicity is common and can
cause major disability and death Reduce risk of delayed neurotoxicity
lower consolidation dose for patients <60defer WBRT for those older patients >60
Radiotherapy remains an effective treatment for patients considered not suitable for chemotherapy
![Page 22: Primary CNS Lymphoma: focus on role of radiation](https://reader035.vdocuments.us/reader035/viewer/2022070403/568139f2550346895da1aacb/html5/thumbnails/22.jpg)
Thank You